NEW YORK – In its newly released report "Percutaneous Coronary Interventions (PCI) in New York State 2007-2009," the Department of Health (DOH) presented data demonstrating that Lenox Hill Hospital had the lowest risk-adjusted mortality rate in the state in 2009 for 2,940 patients undergoing angioplasty, a procedure used to clear blocked heart arteries and increase blood flow.
The report, which provides information on risk factors associated with in-hospital/30-day mortality following a PCI procedure, and tabulates hospital and physician-specific mortality rates, also recognized the superior performance of Long Island Jewish (LIJ) Medical Center and North Shore University Hospital (NSUH), which along with Lenox Hill Hospital are part of the North Shore-LIJ Health System. Over the three-year period covered in the report (2007-09), LIJ was one of six hospitals statewide that had statistically superior outcomes for angioplasty. In addition, NSUH was one of only three hospitals in New York – and the only one on Long Island – that had significantly better outcomes for 935 patients undergoing emergency angioplasty during those three years.
“The state Department of Health’s annual analysis of cardiac outcomes in hospitals across New York has contributed to continuous improvements in the care delivered to New Yorkers with heart disease, which continues to be the number one cause of death in this state and in this country," said Stanley Katz, MD, senior vice president of cardiovascular services for the North Shore-LIJ Health System and chair of cardiology at NSUH and LIJ. “The availability of these reports provides heart patients and their families with a valuable source of information that they can use to make informed decisions about their cardiac care."
Lenox Hill Hospital, a 652-bed, fully accredited, acute care hospital, is recognized nationally as a leader in cardiac care. The nation’s first coronary angioplasty, a procedure that revolutionized cardiac care, was performed at Lenox Hill Hospital in 1978. In the years since, its physicians and surgeons have continued in the vanguard of cardiovascular research and clinical care. In 1991, Lenox Hill Hospital cardiologists were the first in New York to use coronary stents; in 1994, its cardiac surgeons performed the first minimally invasive coronary artery bypass (MIDCAB) in 2001, Lenox Hill was the first hospital to use drug-eluting stents, as part of a national, multicenter clinical trial, and in 2009: Lenox Hill Hospital surgeons performed New York’s first totally endoscopic robotic coronary artery bypass surgery on a beating heart.